# NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

> **NCT00116428** · PHASE3 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 167 (actual)

## Conditions studied

- Heart Diseases
- Arrhythmia
- Atrial Fibrillation

## Interventions

- **DEVICE:** NAVISTAR® THERMOCOOL® Catheter
- **DRUG:** Antiarrhythmic drug

## Key facts

- **NCT ID:** NCT00116428
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-01
- **Primary completion:** 2007-10-01
- **Final completion:** 2011-03-01
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2017-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116428, "NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00116428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*